Pediatrics Archives | 第 3 页，共 7 页 | Certara

On-Demand Webinar

将 PBPK 模型应用于儿科药物开发的最佳实践框架

Pediatric PBPK models have broad application in the drug development process and are being used…

Certara2021 年 4 月 20 日

White Paper

Advancing Pediatric Drug Development Using Simcyp® PBPK

Certara2021 年 3 月 4 日

Case Study

Galderma AKLIEF®（曲法罗汀）获得了 FDA 批准

In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…

Certara2020 年 11 月 9 日

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

Certara2020 年 7 月 14 日

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Certara2020 年 1 月 17 日

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Certara2020 年 1 月 17 日

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

Certara2019 年 6 月 24 日

Publication

Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children

Certara2018 年 6 月 4 日

Publication

Population Pharmacokinetics of Intravenous Linezolid in Premature Infants

Certara2018 年 4 月 9 日

Publication

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations

Certara2018 年 4 月 1 日

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software